MA47112A - Procédés de traitement du syndrome du côlon irritable avec des formulations à libération modifiée ou retardée de linaclotide - Google Patents
Procédés de traitement du syndrome du côlon irritable avec des formulations à libération modifiée ou retardée de linaclotideInfo
- Publication number
- MA47112A MA47112A MA047112A MA47112A MA47112A MA 47112 A MA47112 A MA 47112A MA 047112 A MA047112 A MA 047112A MA 47112 A MA47112 A MA 47112A MA 47112 A MA47112 A MA 47112A
- Authority
- MA
- Morocco
- Prior art keywords
- delayed
- modified
- methods
- release formulations
- treating irritable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662437566P | 2016-12-21 | 2016-12-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA47112A true MA47112A (fr) | 2019-10-30 |
Family
ID=61022424
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA047112A MA47112A (fr) | 2016-12-21 | 2017-12-21 | Procédés de traitement du syndrome du côlon irritable avec des formulations à libération modifiée ou retardée de linaclotide |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3558337A1 (fr) |
| JP (2) | JP2020512292A (fr) |
| CN (1) | CN110475564A (fr) |
| AU (1) | AU2017379082A1 (fr) |
| BR (1) | BR112019012689A2 (fr) |
| CA (1) | CA3048195A1 (fr) |
| EA (1) | EA201991531A1 (fr) |
| MA (1) | MA47112A (fr) |
| MX (2) | MX2019007574A (fr) |
| WO (1) | WO2018119191A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA56128A (fr) * | 2019-06-10 | 2022-04-13 | Ironwood Pharmaceuticals Inc | Traitement de la douleur abdominale associée au syndrome du côlon irritable à diarrhée prédominante |
| IL313184A (en) * | 2021-11-29 | 2024-07-01 | Ironwood Pharmaceuticals Inc | Medicinal preparations for the treatment of visceral pain |
| WO2023196821A2 (fr) * | 2022-04-04 | 2023-10-12 | Thomas Jefferson University | Ciblage de gucy2c de cellule neuropode pour commander la douleur viscérale et l'appétit |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7304036B2 (en) | 2003-01-28 | 2007-12-04 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| US7371727B2 (en) | 2003-01-28 | 2008-05-13 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| RS60101B1 (sr) | 2008-08-15 | 2020-05-29 | Ironwood Pharmaceuticals Inc | Formulacije koje sadrže linaklotid za oralnu primenu |
| WO2011020054A1 (fr) * | 2009-08-13 | 2011-02-17 | Ironwood Pharmaceuticals Inc. | Procédé de modulation de l'effet pharmacodynamique d'agonistes des récepteurs de guanylate cyclase administrés par voie orale |
| EA201290799A1 (ru) | 2010-02-17 | 2013-03-29 | Айронвуд Фармасьютикалз, Инк. | Лечение желудочно-кишечных расстройств |
| LT2603232T (lt) * | 2010-08-11 | 2020-01-27 | Ironwood Pharmaceuticals, Inc. | Stabilios linaklotido vaisto formos |
| PL2776055T3 (pl) | 2011-08-17 | 2017-06-30 | Ironwood Pharmaceuticals, Inc. | Sposoby leczenia zaburzeń żołądkowo-jelitowych |
| AU2014207680B2 (en) * | 2013-01-15 | 2018-09-06 | Ironwood Pharmaceuticals, Inc. | Gastro-retentive sustained-release oral dosage form of a bile acid sequestrant |
| UA119335C2 (uk) * | 2013-12-11 | 2019-06-10 | Айронвуд Фармасьютикалз, Інк. | Композиції лінаклотиду з затриманим вивільненням |
| JP2018516937A (ja) * | 2015-06-05 | 2018-06-28 | アイアンウッド ファーマシューティカルズ インコーポレイテッド | リナクロチドの改変または標的放出製剤 |
-
2017
- 2017-12-21 JP JP2019533167A patent/JP2020512292A/ja active Pending
- 2017-12-21 CA CA3048195A patent/CA3048195A1/fr active Pending
- 2017-12-21 EP EP17833050.2A patent/EP3558337A1/fr active Pending
- 2017-12-21 MX MX2019007574A patent/MX2019007574A/es unknown
- 2017-12-21 EA EA201991531A patent/EA201991531A1/ru unknown
- 2017-12-21 MA MA047112A patent/MA47112A/fr unknown
- 2017-12-21 WO PCT/US2017/067814 patent/WO2018119191A1/fr unknown
- 2017-12-21 BR BR112019012689-9A patent/BR112019012689A2/pt unknown
- 2017-12-21 AU AU2017379082A patent/AU2017379082A1/en active Pending
- 2017-12-21 CN CN201780087073.0A patent/CN110475564A/zh active Pending
-
2019
- 2019-06-21 MX MX2023008839A patent/MX2023008839A/es unknown
-
2022
- 2022-04-27 JP JP2022073214A patent/JP2022093472A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020512292A (ja) | 2020-04-23 |
| MX2019007574A (es) | 2019-09-04 |
| AU2017379082A1 (en) | 2019-07-04 |
| CN110475564A (zh) | 2019-11-19 |
| EP3558337A1 (fr) | 2019-10-30 |
| EA201991531A1 (ru) | 2019-11-29 |
| WO2018119191A1 (fr) | 2018-06-28 |
| MX2023008839A (es) | 2023-08-14 |
| JP2022093472A (ja) | 2022-06-23 |
| BR112019012689A2 (pt) | 2019-11-19 |
| CA3048195A1 (fr) | 2018-06-28 |
| WO2018119191A9 (fr) | 2018-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA43380A (fr) | Récepteurs chimériques modifiés et compositions et procédés associés | |
| MA45779A (fr) | Polypeptides immunomdulateurs et compositions et procédés associés | |
| MA50569A (fr) | Ensembles de remplissage-finition et procédés associés | |
| MA43711A (fr) | Procédés de production de l-glufosinate | |
| LT3368688T (lt) | Kompozicijos ir būdai, skirti modifikuotų citozinų nustatymui sekvenavimu | |
| MA45426A (fr) | Procédés, kits, agents et appareils de transduction | |
| MA52506A (fr) | Procédés de traitement d'infections par des virus nipah | |
| ES2981519T3 (es) | Formulaciones de virus adeno-asociados | |
| DK3329002T3 (da) | Transthyretin (ttr)-irna-sammensætninger og fremgangsmåder til anvendelse deraf til behandling eller forebyggelse af ttr-forbundne sygdomme | |
| EP3188741A4 (fr) | Compositions et méthodes pour le traitement d'une maladie ou d'un trouble inflammatoire | |
| IL266162A (en) | Adeno-associated virus purification methods | |
| MA40824A (fr) | Particules de cmv de type virus modifié | |
| MA41863A (fr) | Compositions et procédés permettant de traiter une anémie | |
| MA46865A (fr) | Compositions de caryophyllène, appareils et procédés | |
| ES2981480T3 (es) | Sistema de procesamiento de imágenes | |
| IL251606B (en) | Methods and systems for diagnosing irritable bowel syndrome from inflammatory bowel disease and celiac disease | |
| DK3662925T3 (da) | Sammensætning, der omfatter fsh, til behandling af infertilitet | |
| MA47112A (fr) | Procédés de traitement du syndrome du côlon irritable avec des formulations à libération modifiée ou retardée de linaclotide | |
| DK3331610T3 (da) | Midler til anvendelse til behandling af gliom | |
| BR112017021850A2 (pt) | detecção de isoformas específicas de clusterina | |
| MA52920A (fr) | Compositions et procédés se rapportant à des agonistes de pyridinoylpipéridine 5-ht1f | |
| BR112016024667A2 (pt) | composições de revestimento melhorado e processos para fabricação das mesmas | |
| MA41961A (fr) | Procédés de régénération d'adsorbants solides | |
| MA41202A (fr) | Copolymères polydiallymine réticulé pour le traitement du diabète de type 2 | |
| DK3096775T3 (da) | SOCS-mimetika til behandling af sygdomme |